
Journal of Medicinal Chemistry p. 674 - 688 (1994)
Update date:2022-08-03
Brown
Brown
Bickett
Chambers
Davies
Deaton
Drewry
Foley
McElroy
Gregson
McGeehan
Myers
Norton
Salovich
Schoenen
Ward
Systematic modification of the presumed P1 side chain in a series of (carboxyalkyl)amino-based inhibitors of matrix metalloproteinases enabled identification of the 2-(1,3-dihydro-1,3-dioxo-2H-benz[f]isoindol-2-yl)ethyl group as a preferred substituent imparting potent inhibition of the enzymes collagenase and gelatinase. It was subsequently found that the P2'-P3' residues in this series could be replaced by small non-peptide residues, while maintaining inhibitory potency. The imide group in this series of compounds can undergo autocatalytic hydrolysis under neutral conditions.
View MoreShanghai united Scientific Co.,Ltd.
Contact:+86-21-53535353
Address:28F No.900 huaihai Road Shanghai China
Shandong Xinke Petrochemical Co., Ltd.
Contact:+86-546-7277016
Address:Gudao Industrial Park, Hekou District, Dongying, Shandong Province, China
Hebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
ALPHA PHARMACEUTICAL CO,LTD JIANGSU
Contact:+86-527-84829968,+86-527-84829998
Address:suqian city
Doi:10.1021/jo00085a038
(1994)Doi:10.1016/S0040-4039(00)73719-1
(1993)Doi:10.1016/j.tet.2006.05.050
(2006)Doi:10.1021/ic50217a054
(1981)Doi:10.1021/jo00086a034
(1994)Doi:10.1016/j.tetlet.2014.01.009
(2014)